Zhitong Finance APP Newstimepilot, Saisheng Pharmaceutical (06600) announced that on May 7, 2024, in accordance with the rules of the post-IPO share option plantimepilot: 7000 share options granted under the Post-IPO Share Option Plan have lapsed; and 90,000 share options granted under the Post-IPO Share Option Plan have been exercised.